Pfizer Korea’s attempts to expand reimbursement for its third-generation ALK inhibitor Lorviqua (lorlatinib) do not seem to bear fruit easily, according to industry sources.Some analysts have speculated that Pfizer Korea might have made a strategic choice in the drug price negotiations due to Lorviq
Bridge Biotherapeutics said Wednesday it has signed collaborative research agreements with the University of Colorado and Emory University to explore the potential for expanding the indications of BBT-877, an autotaxin inhibitor, as an immuno-oncology agent.The company added that the joint researche
The rift between the government and the medical community is expected to deepen as Lim Hyun-taek, the president-elect of the Korean Medical Association (KMA), has firmly demanded a presidential apology and the dismissal of both the Minister and Vice Minister of Health and Welfare if the government w
Myongji Hospital and Rokit Healthcare, a company specializing in organ regeneration, have agreed to join forces to research and develop diabetic foot treatment technology using 3D bioprinting.Myongji Hospital President Kim Jin-goo and Rokit Healthcare Chairman and CEO You Seok-hwan signed the agreem
Hanmi Group Chairman Song Young-sook and her daughter have gained a decisive edge in the ongoing management conflict within the founding family after securing support from the National Pension Service (NPS), which has emerged as a deciding factor in this corporate governance battle.On Tuesday evenin
If a liver cancer patient has undergone third-line therapy following immunotherapies Tecentriq (atezolizumab) and Avastin (bevacizumab), but the liver cancer has progressed, leading to lung metastasis, what is the subsequent treatment plan?What is the rate of patients who do not respond to this thir
A local court denied the preliminary injunction filed by the late Hanmi founders' sons—Coree Group Chairman Lim Jong-yoon and Hanmi Fine Chemical CEO Lim Jong-hoon—to halt the issuance of new shares to OCI Holdings. The merger between Hanmi Pharmaceutical Group and OCI Group is currently led by Hanm
Bluemtec has made a strategic investment in Medistaff, a secure messaging platform for physicians, becoming the latter’s second-largest shareholder.Bluemtec said Tuesday that it has recently acquired Medistaff's common stock, making it the company's second-largest shareholder. Bluemtec now owns 16.6
As the resignations of interns and residents enter a second month, various healthcare workers, including nurses, are reeling from the growing workload.Especially worrying is not only physician assistant (PA) nurses but also general-duty nurses are being forced to do doctors' work, resulting in a dan
The health authorities recently designated “systemic pustular psoriasis” as a rare disease and included it in this year's special calculation targets, opening the way for the use of Spevigo (spesolimab) for the disease’s treatment.However, a big hurdle of insurance benefits remains before its treatm
Celltrion held its annual general shareholders meeting on Tuesday with covering agenda items including approval of certain changes to the articles of incorporation, appointment of directors, appointment of outside directors to serve as auditors, appointment of auditors, approval of director compensa
The U.S. Congress’ proposal of the Biosecure Act, which targets Chinese biotech companies, will increase supply chain instability in the global pharmaceutical industry but it may benefit top CDMOs such as Lonza and Samsung Biologics in the mid- to long-term, a local brokerage said.According to a rep
Backing away from its hardline stance, the Korean government has expressed its willingness to become more flexible in imposing punitive measures against resigned interns and residents and talk with them.Still, the conciliatory moves seem to have fallen short of changing the minds of trainee doctors,
Despite predictions that its high cost as a premium vaccine would be a barrier to market expansion, GSK's shingles vaccine, Shingrix, has claimed the top sales spot in the market in its first year of release.Shingles is caused when the varicella-zoster virus (VZV), which causes chickenpox, becomes r
Kakao Healthcare said Tuesday that it has signed a business agreement with healthcare startup Brave Company to develop and spread exercise content for proper blood sugar management.Through the agreement, Kakao Healthcare's medical experts and Brave Company's exercise experts will jointly plan and de
Dong-A ST said it signed a joint sales agreement with Yuyu Pharma on Monday for the peripheral circulation improvement drug Tanamine Tablet at the latter’s headquarters in Shindang-dong, Jung-gu, Seoul.The two companies' senior managers, including Dong-A ST CEO Kim Min-young and Yuyu Pharma CEO Yu W
Medytox, a South Korean manufacturer of botulinum toxin (BTX), said on Tuesday that it has entered a five-year contract with Brazilian pharmaceutical firm Blau Farmacêutica to provide BTX products valued at $73 million.Under the agreement, the BTX items shipped to Blau will include the newest produc
In an unfolding corporate drama at Hanmi Group, a major South Korean conglomerate, the company announced the sudden removal of two key figures from their leadership roles, only days before their annual shareholders' meeting. Hanmi Science's President Lim Jong-yoon and Hanmi Pharmaceuticals' Presiden
Multiple sclerosis (MS), a rare and incurable disease that affects women of childbearing age between 20 and 40, is characterized by invading the central nervous system, such as the brain and spinal cord, and damaging the nerves, resulting in various symptoms and worsening with repeated relapses.MS c
AriBio said Monday that it has concluded an exclusive distribution agreement with a Chinese pharmaceutical company for AR1001, an oral treatment for Alzheimer's disease, in China. The agreement is valued at about 1.02 trillion won (5.6 billion RMB or $770 million).Under the exclusive sales contract